{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:57:05Z","timestamp":1782932225032,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974468"],"award-info":[{"award-number":["81974468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04249-w","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T02:53:57Z","timestamp":1772938437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineered lipid hybrid nanoparticles for targeted delivery of SH2 superbinder and breast cancer therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuhe","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caidi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songwei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"4249_CR1","doi-asserted-by":"publisher","unstructured":"DeClue JE, Sadowski I, Martin GS, Pawson T. A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proceedings of the National Academy of Sciences. 1987;84:9064\u20138. https:\/\/doi.org\/10.1073\/pnas.84.24.9064","DOI":"10.1073\/pnas.84.24.9064"},{"key":"4249_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0092-8674(03)01077-8","volume":"116","author":"T Pawson","year":"2004","unstructured":"Pawson T. Specificity in Signal Transduction: From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems. Cell. 2004;116:191\u2013203. https:\/\/doi.org\/10.1016\/S0092-8674(03)01077-8.","journal-title":"Cell"},{"key":"4249_CR3","doi-asserted-by":"publisher","first-page":"ra68","DOI":"10.1126\/scisignal.2003021","volume":"5","author":"T Kaneko","year":"2012","unstructured":"Kaneko T, Huang H, Cao X, Li X, Li C, Voss C, et al. Superbinder SH2 Domains Act as Antagonists of Cell Signaling. Sci Signal. 2012;5:ra68\u201368. https:\/\/doi.org\/10.1126\/scisignal.2003021.","journal-title":"Sci Signal"},{"key":"4249_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nchembio.2178","volume":"12","author":"Y Bian","year":"2016","unstructured":"Bian Y, Li L, Dong M, Liu X, Kaneko T, Cheng K, et al. Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016;12:959\u201366. https:\/\/doi.org\/10.1038\/nchembio.2178.","journal-title":"Nat Chem Biol"},{"key":"4249_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13046-018-0812-5","volume":"37","author":"A Liu","year":"2018","unstructured":"Liu A, Xu H, Gao Y, Luo D, Li Z, Voss C, et al. (Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling. J Experimental Clin Cancer Res. 2018;37:138. https:\/\/doi.org\/10.1186\/s13046-018-0812-5.","journal-title":"J Experimental Clin Cancer Res"},{"key":"4249_CR6","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1002\/ctm2.337","volume":"11","author":"A Liu","year":"2021","unstructured":"Liu A, Zhou J, Bi X, Hou G, Li SS, Chen Q, et al. Aptamer-SH2 superbinder\u2010based targeted therapy for pancreatic ductal adenocarcinoma. Clin Transl Med. 2021;11:e337. https:\/\/doi.org\/10.1002\/ctm2.337.","journal-title":"Clin Transl Med"},{"key":"4249_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jb\/mvw085","volume":"161","author":"Y Fujiwara","year":"2017","unstructured":"Fujiwara Y, Wada K, Kabuta T. Lysosomal degradation of intracellular nucleic acids\u2014multiple autophagic pathways. J Biochem. 2017;161:145\u201354. https:\/\/doi.org\/10.1093\/jb\/mvw085.","journal-title":"J Biochem"},{"key":"4249_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther. 2022;7:1\u201313. https:\/\/doi.org\/10.1038\/s41392-022-00966-4.","journal-title":"Signal Transduct Target Ther"},{"key":"4249_CR9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jconrel.2024.01.038","volume":"366","author":"J Wu","year":"2024","unstructured":"Wu J, Roesger S, Jones N, Hu C. Cell-penetrating peptides for transmucosal delivery of proteins. J Controlled Release. 2024;366:864\u201378. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.038.","journal-title":"J Controlled Release"},{"key":"4249_CR10","doi-asserted-by":"publisher","first-page":"102785","DOI":"10.1016\/j.copbio.2022.102785","volume":"78","author":"B Ikuagwu","year":"2022","unstructured":"Ikuagwu B, Tullman-Ercek D. Virus-like particles for drug delivery: a review of methods and applications. Curr Opin Biotechnol. 2022;78:102785. https:\/\/doi.org\/10.1016\/j.copbio.2022.102785.","journal-title":"Curr Opin Biotechnol"},{"key":"4249_CR11","doi-asserted-by":"publisher","first-page":"101751","DOI":"10.1016\/j.progpolymsci.2023.101751","volume":"146","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Shi J, Ma B, Zhou Y-N. Functionalization of polymers for intracellular protein delivery. Prog Polym Sci. 2023;146:101751. https:\/\/doi.org\/10.1016\/j.progpolymsci.2023.101751.","journal-title":"Prog Polym Sci"},{"key":"4249_CR12","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1039\/C9TB01913H","volume":"7","author":"Y Wang","year":"2019","unstructured":"Wang Y, Pei Z, Feng W, Pei Y. Stimuli-responsive supramolecular nano-systems based on pillar[n]arenes and their related applications. J Mater Chem B. 2019;7:7656\u201375. https:\/\/doi.org\/10.1039\/C9TB01913H.","journal-title":"J Mater Chem B"},{"key":"4249_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2023.03.027","volume":"357","author":"ER Soto","year":"2023","unstructured":"Soto ER, Specht CA, Rus F, Lee CK. An efficient (nano) silica - In glucan particles protein encapsulation approach for improved thermal stability. J Controlled Release. 2023;357:175\u201384. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.027.","journal-title":"J Controlled Release"},{"key":"4249_CR14","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1007\/s13346-023-01498-2","volume":"14","author":"Y-S Chen","year":"2024","unstructured":"Chen Y-S, Hong Z-X, Lin Y-T, Tsao E-C, Chen P-Y, Liu C-A, et al. Efficiency of PGK1 proteins delivered to the brain via a liposomal system through intranasal route administration for the treatment of spinocerebellar ataxia type 3. Drug Deliv Transl Res. 2024;14:1940\u201353. https:\/\/doi.org\/10.1007\/s13346-023-01498-2.","journal-title":"Drug Deliv Transl Res"},{"key":"4249_CR15","doi-asserted-by":"publisher","first-page":"102287","DOI":"10.1016\/j.nantod.2024.102287","volume":"56","author":"Y Li","year":"2024","unstructured":"Li Y, Yu X, Chen Q, Wang H. Polyresorcinols for intracellular protein delivery. Nano Today. 2024;56:102287. https:\/\/doi.org\/10.1016\/j.nantod.2024.102287.","journal-title":"Nano Today"},{"key":"4249_CR16","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.nantod.2021.101215","volume":"39","author":"G Wang","year":"2021","unstructured":"Wang G, Chen S, Qiu N, Wu B. Virus-mimetic DNA-ejecting polyplexes for efficient intracellular cancer gene delivery. Nano Today. 2021;39:101215. https:\/\/doi.org\/10.1016\/j.nantod.2021.101215.","journal-title":"Nano Today"},{"key":"4249_CR17","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.1021\/acs.nanolett.1c03031","volume":"21","author":"S Zhang","year":"2021","unstructured":"Zhang S, Lv J, Gao P, Feng Q, Wang H, Cheng Y. A pH-Responsive Phase-Transition Polymer with High Serum Stability in Cytosolic Protein Delivery. Nano Lett. 2021;21:7855\u201361. https:\/\/doi.org\/10.1021\/acs.nanolett.1c03031.","journal-title":"Nano Lett"},{"key":"4249_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jconrel.2023.01.064","volume":"355","author":"J Lv","year":"2023","unstructured":"Lv J, Yang Z, Wang C, Duan J. Efficient intracellular and in vivo delivery of toxin proteins by a ROS-responsive polymer for cancer therapy. J Controlled Release. 2023;355:160\u201370. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.064.","journal-title":"J Controlled Release"},{"key":"4249_CR19","doi-asserted-by":"publisher","first-page":"eadl4336","DOI":"10.1126\/sciadv.adl4336","volume":"10","author":"E Tan","year":"2024","unstructured":"Tan E, Wan T, Pan Q, Duan J, Zhang S, Wang R, et al. Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders. Sci Adv. 2024;10:eadl4336. https:\/\/doi.org\/10.1126\/sciadv.adl4336.","journal-title":"Sci Adv"},{"key":"4249_CR20","doi-asserted-by":"publisher","first-page":"24139","DOI":"10.1021\/acsnano.4c05270","volume":"18","author":"G Kwak","year":"2024","unstructured":"Kwak G, Grewal A, Slika H, Mess G, Li H, Kwatra M, et al. Brain Nucleic Acid Delivery and Genome Editing via Focused Ultrasound-Mediated Blood\u2013Brain Barrier Opening and Long-Circulating Nanoparticles. ACS Nano. 2024;18:24139\u201353. https:\/\/doi.org\/10.1021\/acsnano.4c05270.","journal-title":"ACS Nano"},{"issue":"10","key":"4249_CR21","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1021\/acs.biomac.5c00954","volume":"26","author":"Q Li","year":"2025","unstructured":"Li Q, Zhu Y, Ding J, Pan W, Hu Y, Lu J, et al. Construction of ROS-Responsive Poly(\u03b2-amino ester)-poly(\u03b2-thioether ester) Copolymer for Enhancing Gene Delivery and Gene Therapy. Biomacromolecules. 2025;26(10):6702\u201315. https:\/\/doi.org\/10.1021\/acs.biomac.5c00954.","journal-title":"Biomacromolecules"},{"key":"4249_CR22","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1021\/nn500704t","volume":"8","author":"KL Kozielski","year":"2014","unstructured":"Kozielski KL, Tzeng SY, Hurtado De Mendoza BA, Green JJ. Bioreducible Cationic Polymer-Based Nanoparticles for Efficient and Environmentally Triggered Cytoplasmic siRNA Delivery to Primary Human Brain Cancer Cells. ACS Nano. 2014;8:3232\u201341. https:\/\/doi.org\/10.1021\/nn500704t.","journal-title":"ACS Nano"},{"key":"4249_CR23","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.1021\/nn402657d","volume":"7","author":"M Keeney","year":"2013","unstructured":"Keeney M, Ong S-G, Padilla A, Yao Z, Goodman S, Wu JC, et al. Development of Poly(\u03b2-amino ester)-Based Biodegradable Nanoparticles for Nonviral Delivery of Minicircle DNA. ACS Nano. 2013;7:7241\u201350. https:\/\/doi.org\/10.1021\/nn402657d.","journal-title":"ACS Nano"},{"key":"4249_CR24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/nn504905q","volume":"9","author":"A Mangraviti","year":"2015","unstructured":"Mangraviti A, Tzeng SY, Kozielski KL, Wang Y, Jin Y, Gullotti D, et al. Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo. ACS Nano. 2015;9:1236\u201349. https:\/\/doi.org\/10.1021\/nn504905q.","journal-title":"ACS Nano"},{"key":"4249_CR25","doi-asserted-by":"publisher","first-page":"8041","DOI":"10.1021\/nn302639r","volume":"6","author":"PC DeMuth","year":"2012","unstructured":"DeMuth PC, Moon JJ, Suh H, Hammond PT, Irvine DJ. Releasable Layer-by-Layer Assembly of Stabilized Lipid Nanocapsules on Microneedles for Enhanced Transcutaneous Vaccine Delivery. ACS Nano. 2012;6:8041\u201351. https:\/\/doi.org\/10.1021\/nn302639r.","journal-title":"ACS Nano"},{"key":"4249_CR26","doi-asserted-by":"publisher","first-page":"11855","DOI":"10.1021\/acsnano.3c03166","volume":"17","author":"X Cheng","year":"2023","unstructured":"Cheng X, Hu S, Cheng K. Microneedle Patch Delivery of PROTACs for Anti-Cancer Therapy. ACS Nano. 2023;17:11855\u201368. https:\/\/doi.org\/10.1021\/acsnano.3c03166.","journal-title":"ACS Nano"},{"key":"4249_CR27","doi-asserted-by":"publisher","first-page":"16743","DOI":"10.1021\/acsnano.3c03279","volume":"17","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen P-H, Li B, Guo H, Zhu J, Dang Z, et al. Comprehensively Optimizing Fenton Reaction Factors for Antitumor Chemodynamic Therapy by Charge-Reversal Theranostics. ACS Nano. 2023;17:16743\u201356. https:\/\/doi.org\/10.1021\/acsnano.3c03279.","journal-title":"ACS Nano"},{"key":"4249_CR28","doi-asserted-by":"publisher","first-page":"17799","DOI":"10.1021\/acsnano.3c03269","volume":"17","author":"X Wang","year":"2023","unstructured":"Wang X, Li Y, Wang X, Sandoval DM, He Z. Guanidyl-Rich Poly(\u03b2 Amino Ester)s for Universal Functional Cytosolic Protein Delivery and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Ribonucleoprotein Based Gene Editing. ACS Nano. 2023;17:17799\u2013810. https:\/\/doi.org\/10.1021\/acsnano.3c03269.","journal-title":"ACS Nano"},{"key":"4249_CR29","doi-asserted-by":"publisher","first-page":"102092","DOI":"10.1016\/j.nano.2019.102092","volume":"22","author":"C Zou","year":"2019","unstructured":"Zou C, Jiang G, Gao X, Zhang W. Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (\u03b2-amino ester) nano-vaccines for melanoma. Nanomedicine. 2019;22:102092. https:\/\/doi.org\/10.1016\/j.nano.2019.102092.","journal-title":"Nanomedicine"},{"key":"4249_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/pharmaceutics15041053","volume":"15","author":"A Vogelaar","year":"2023","unstructured":"Vogelaar A, Marcotte S, Cheng J, Oluoch B, Zaro J. Use of Microfluidics to Prepare Lipid-Based Nanocarriers. Pharmaceutics. 2023;15:1053. https:\/\/doi.org\/10.3390\/pharmaceutics15041053.","journal-title":"Pharmaceutics"},{"key":"4249_CR31","doi-asserted-by":"publisher","first-page":"114197","DOI":"10.1016\/j.addr.2022.114197","volume":"184","author":"G Prakash","year":"2022","unstructured":"Prakash G, Shokr A, Willemen N, Bashir SM. Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids. Adv Drug Deliv Rev. 2022;184:114197. https:\/\/doi.org\/10.1016\/j.addr.2022.114197.","journal-title":"Adv Drug Deliv Rev"},{"key":"4249_CR32","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1039\/C4NR01510J","volume":"6","author":"Z Yang","year":"2014","unstructured":"Yang Z, Yu B, Zhu J, Huang X, Xie J, Xu S, et al. A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia. Nanoscale. 2014;6:9742\u201351. https:\/\/doi.org\/10.1039\/C4NR01510J.","journal-title":"Nanoscale"},{"key":"4249_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2009.08.019","volume":"141","author":"CG Koh","year":"2010","unstructured":"Koh CG, Zhang X, Liu S, Golan S. Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing. J Controlled Release. 2010;141:62\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2009.08.019.","journal-title":"J Controlled Release"},{"key":"4249_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","volume":"24","author":"D Fischer","year":"2003","unstructured":"Fischer D, Li Y, Ahlemeryer B, Krieglstein J. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 2003;24:1121\u201331. https:\/\/doi.org\/10.1016\/S0142-9612(02)00445-3.","journal-title":"Biomaterials"},{"key":"4249_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","volume":"240","author":"Y-N Zhang","year":"2016","unstructured":"Zhang Y-N, Poon W, Tavares AJ, McGilvray ID. Nanoparticle\u2013liver interactions: Cellular uptake and hepatobiliary elimination. J Controlled Release. 2016;240:332\u201348. https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.020.","journal-title":"J Controlled Release"},{"key":"4249_CR36","doi-asserted-by":"publisher","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","volume":"18","author":"X Qian","year":"2024","unstructured":"Qian X, Yang H, Ye Z, Gao B, Qian Z, Ding Y, et al. Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer. ACS Nano. 2024;18:15864\u201377. https:\/\/doi.org\/10.1021\/acsnano.4c02947.","journal-title":"ACS Nano"},{"key":"4249_CR37","doi-asserted-by":"publisher","first-page":"22129","DOI":"10.1021\/acsnano.3c09581","volume":"17","author":"R Jiang","year":"2023","unstructured":"Jiang R, Li L, Li M. Biomimetic Construction of Degradable DNAzyme-Loaded Nanocapsules for Self-Sufficient Gene Therapy of Pulmonary Metastatic Breast Cancer. ACS Nano. 2023;17:22129\u201344. https:\/\/doi.org\/10.1021\/acsnano.3c09581.","journal-title":"ACS Nano"},{"key":"4249_CR38","doi-asserted-by":"publisher","first-page":"102285","DOI":"10.1016\/j.mtbio.2025.102285","volume":"35","author":"H Deng","year":"2025","unstructured":"Deng H, Li Q, Wang B, Yu H, Sun S, Li Z, et al. Reshaping tumor immune microenvironment through ROS-responsive prodrug polyplexes via synergistic effect of CRISPRi system and epigenetic inhibitor for breast cancer therapy. Mater Today Bio. 2025;35:102285. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102285.","journal-title":"Mater Today Bio"},{"key":"4249_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.actbio.2025.04.031","volume":"199","author":"W Zou","year":"2025","unstructured":"Zou W, Huo B, Tu Y, Zhu Y, Hu Y, Li Q, et al. Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma. Acta Biomater. 2025;199:361\u201373. https:\/\/doi.org\/10.1016\/j.actbio.2025.04.031.","journal-title":"Acta Biomater"},{"key":"4249_CR40","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu S, Wen Y, Shan X, Ma X, Yang C, Cheng X, et al. Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination. Nat Commun. 2024;15:9471. https:\/\/doi.org\/10.1038\/s41467-024-53914-x.","journal-title":"Nat Commun"},{"key":"4249_CR41","doi-asserted-by":"publisher","first-page":"25575","DOI":"10.1039\/C8RA05014G","volume":"8","author":"W Xu","year":"2018","unstructured":"Xu W, Yan X, Liu N, Wu G. P1c peptide decorated liposome targeting \u03b1v\u03b23-expressing tumor cells in vitro and in vivo. RSC Adv. 2018;8:25575\u201383. https:\/\/doi.org\/10.1039\/C8RA05014G.","journal-title":"RSC Adv"},{"issue":"44","key":"4249_CR42","doi-asserted-by":"publisher","first-page":"e2502231","DOI":"10.1002\/smll.202502231","volume":"21","author":"SL Yap","year":"2025","unstructured":"Yap SL, Dekiwadia C, Della Gaspera E, Drummond CJ, Conn CE, Tran N. Bypassing Endocytic Barriers: Visualizing Membrane Fusion and Endosomal Escape of Cubic Phase Lipid Nanoparticles (Cubosomes). Small. 2025;21(44):e2502231. https:\/\/doi.org\/10.1002\/smll.202502231.","journal-title":"Small"},{"key":"4249_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2025.01.004","volume":"379","author":"X Wang","year":"2025","unstructured":"Wang X, Liu G, Pu X, Ren T, Zhang F, Shen M, et al. Combating cisplatin-resistant lung cancer using a coiled-coil lipopeptides modified membrane fused drug delivery system. J Control Release. 2025;379:45\u201358. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.004.","journal-title":"J Control Release"},{"key":"4249_CR44","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","volume":"18","author":"X Han","year":"2023","unstructured":"Han X, Alameh M-G, Butowska K, Knox JJ, Lundgreen K, Ghattas M, et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat Nanotechnol. 2023;18:1105\u201314. https:\/\/doi.org\/10.1038\/s41565-023-01404-4.","journal-title":"Nat Nanotechnol"},{"key":"4249_CR45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","volume":"19","author":"AY Jiang","year":"2024","unstructured":"Jiang AY, Witten J, Raji IO, Eweje F, MacIsaac C, Meng S, et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat Nanotechnol. 2024;19:364\u201375. https:\/\/doi.org\/10.1038\/s41565-023-01548-3.","journal-title":"Nat Nanotechnol"},{"issue":"Suppl 3","key":"4249_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/jitc-2021-SITC2021.603","volume":"9","author":"J Dey","year":"2021","unstructured":"Dey J, Liu P, Mayo M, KarnikBin R, Yang B, Dixit V, et al. 603 Targeted STAT3 degradation leads to remodeling of an immunosuppressive tumor microenvironment and subsequent sensitization to immune checkpoint therapy. J Immunother Cancer. 2021;9(Suppl 3):633\u2013633. https:\/\/doi.org\/10.1136\/jitc-2021-SITC2021.603.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"4249_CR47","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.ymthe.2024.03.035","volume":"32","author":"S Ganesh","year":"2024","unstructured":"Ganesh S, Kim MJ, Lee J, Feng X, Ule K, Mahan A, et al. RNAi mediated silencing of STAT3\/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors. Mol Ther. 2024;32(6):1895\u2013916. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.035.","journal-title":"Mol Ther"},{"key":"4249_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ceb.2009.01.028","volume":"21","author":"T Hunter","year":"2009","unstructured":"Hunter T. Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol. 2009;21:140\u20136. https:\/\/doi.org\/10.1016\/j.ceb.2009.01.028.","journal-title":"Curr Opin Cell Biol"},{"key":"4249_CR49","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1101\/gr.128819.111","volume":"22","author":"L Li","year":"2012","unstructured":"Li L, Tibiche C, Fu C, Kaneko T, Moran MF, Schiller MR, et al. The human phosphotyrosine signaling network: Evolution and hotspots of hijacking in cancer. Genome Res. 2012;22:1222\u201330. https:\/\/doi.org\/10.1101\/gr.128819.111.","journal-title":"Genome Res"},{"key":"4249_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"key":"4249_CR51","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, et al. Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol. 2011;29:1046\u201351. https:\/\/doi.org\/10.1038\/nbt.1990.","journal-title":"Nat Biotechnol"},{"key":"4249_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature14119","volume":"519","author":"T Pemovska","year":"2015","unstructured":"Pemovska T, Johnson E, Kontro M, Repasky GA, Chen J, Wells P, et al. Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation. Nature. 2015;519:102\u20135. https:\/\/doi.org\/10.1038\/nature14119.","journal-title":"Nature"},{"key":"4249_CR53","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/FTD.0b013e3181f4d9c5","volume":"32","author":"S Shayani","year":"2010","unstructured":"Shayani S. Dasatinib, a Multikinase Inhibitor: Therapy, Safety, and Appropriate Management of Adverse Events. Ther Drug Monit. 2010;32:680. https:\/\/doi.org\/10.1097\/FTD.0b013e3181f4d9c5.","journal-title":"Ther Drug Monit"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04249-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:22:29Z","timestamp":1776248549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04249-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4249"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04249-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by the Animal Ethics Committee of Taizhou University (IACUC number: TZXY-2024-20241147) and Huazhong University of Science and Technology (IACUC number:4062).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"358"}}